Author

Fangqiong Li

Institution: Haisco Pharmaceutical Group Co., Ltd. (China)

Observed institutions: Chinese People's Armed Police Force, Haisco Pharmaceutical Group Co., Ltd. (China)

ORCID: 0009-0001-3641-3304

Observed ORCID: 0009-0001-3641-3304

OpenAlex ID: A5028338275

Guizhi Shaoyao Zhimu granules attenuate bone destruction in mice with collagen-induced arthritis by promoting mitophagy of osteoclast precursors to inhibit osteoclastogenesis

2023 · Huan Yao, Li Xiang, et al. · Phytomedicine · 33

Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions

2019 · Lihua Wu, Chang Xu, et al. · Drug Design Development and Therapy · 3

Wcn26-5558 Efficacy and Safety of Hsk39297, a Once-daily Oral Cfb Inhibitor, in Patients With Primary Immunoglobulin a Nephropathy: a Randomized, Double-blind, Placebo-controlled Phase Ii Trial

2026 · Jicheng Lv, Jiang Liu, et al. · Kidney International Reports · 2

Efficacy and safety of HSK39297 monotherapy in patients with paroxysmal nocturnal hemoglobinuria

2026 · Yuemin Gong, Lina Zhang, et al. · Chinese Medical Journal · 1

Pharmacokinetics and Safety of Polaprezinc Granules Oral Administration in Healthy Chinese Volunteers Under Fasting and Fed Conditions

2025 · Min Xiao, Tian Dou, et al. · Clinical and Translational Science · 1

Abstract LB405: Novel brain-penetrant BRAF paradox breaker HSK42360 demonstrates promising antitumor activity in patients with BRAF-mutant glioma

2026 · Shidong Gao, Meilin Qian, et al. · Cancer Research

Efficacy and safety of HSK16149 for postoperative pain in Chinese patients after orthopedic surgery: a phase 2 randomized clinical trial

2026 · Lina Yang, Shijin Ma, et al. · International Journal of Surgery

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of HSK39297 in Chinese Healthy Subjects: A Phase 1 Clinical Trial

2025 · Yuyang Dai, Feng Wu, et al. · Clinical and Translational Science

Study on Dexamethasone Thermosensistivie in Situ Gel for Treating Deafness

2006 · Fangqiong Li · Zhōnghuá yàoxué zázhì

Works count: 9

Citation count: 40

H-index: 2

I10-index: 1